Literature DB >> 11292806

Isogenic strain construction and gene targeting in Candida dubliniensis.

P Staib1, G P Moran, D J Sullivan, D C Coleman, J Morschhäuser.   

Abstract

Candida dubliniensis is a recently described opportunistic fungal pathogen that is closely related to Candida albicans but differs from it with respect to epidemiology, certain virulence characteristics, and the ability to develop fluconazole resistance in vitro. A comparison of C. albicans and C. dubliniensis at the molecular level should therefore provide clues about the mechanisms used by these two species to adapt to their human host. In contrast to C. albicans, no auxotrophic C. dubliniensis strains are available for genetic manipulations. Therefore, we constructed homozygous ura3 mutants from a C. dubliniensis wild-type isolate by targeted gene deletion. The two URA3 alleles were sequentially inactivated using the MPA(R)-flipping strategy, which is based on the selection of integrative transformants carrying a mycophenolic acid resistance marker that is subsequently deleted again by site-specific, FLP-mediated recombination. The URA3 gene from C. albicans (CaURA3) was then used as a selection marker for targeted integration of a fusion between the C. dubliniensis MDR1 (CdMDR1) promoter and a C. albicans-adapted GFP reporter gene. Uridine-prototrophic transformants were obtained with high frequency, and all transformants of two independent ura3-negative parent strains had correctly integrated the reporter gene fusion into the CdMDR1 locus, demonstrating that the CaURA3 gene can be used for efficient and specific targeting of recombinant DNA into the C. dubliniensis genome. Transformants carrying the reporter gene fusion did not exhibit detectable fluorescence during growth in yeast extract-peptone-dextrose medium in vitro, suggesting that CdMDR1 is not significantly expressed under these conditions. Fluconazole had no effect on MDR1 expression, but the addition of the drug benomyl strongly activated the reporter gene fusion in a dose-dependent fashion, demonstrating that the CdMDR1 gene, which encodes an efflux pump mediating resistance to toxic compounds, is induced by the presence of certain drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292806      PMCID: PMC99503          DOI: 10.1128/JB.183.9.2859-2865.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  Allele-specific gene targeting in Candida albicans results from heterology between alleles.

Authors:  Kyle Yesland; William A Fonzi
Journal:  Microbiology (Reading)       Date:  2000-09       Impact factor: 2.777

2.  Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis.

Authors:  P Staib; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

3.  Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.

Authors:  S Wirsching; S Michel; G Köhler; J Morschhäuser
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

4.  Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.

Authors:  I Polacheck; J Strahilevitz; D Sullivan; S Donnelly; I F Salkin; D C Coleman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Molecular aspects of fluconazole resistance development in Candida albicans.

Authors:  R Franz; M Ruhnke; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

6.  Isolation of C. dubliniensis from insulin-using diabetes mellitus patients.

Authors:  A M Willis; W A Coulter; D J Sullivan; D C Coleman; J R Hayes; P M Bell; P J Lamey
Journal:  J Oral Pathol Med       Date:  2000-02       Impact factor: 4.253

7.  Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.

Authors:  S Wirsching; S Michel; J Morschhäuser
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  A molecular genetic system for the pathogenic yeast Candida dubliniensis.

Authors:  P Staib; S Michel; G Köhler; J Morschhäuser
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

Review 9.  Recent developments in molecular genetics of Candida albicans.

Authors:  M D De Backer; P T Magee; J Pla
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

10.  Candida dubliniensis fungemia: the first four cases in North America.

Authors:  M E Brandt; L H Harrison; M Pass; A N Sofair; S Huie; R K Li; C J Morrison; D W Warnock; R A Hajjeh
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

View more
  16 in total

Review 1.  Molecular genetic and genomic approaches to the study of medically important fungi.

Authors:  P T Magee; Cheryl Gale; Judith Berman; Dana Davis
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

3.  Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain.

Authors:  Teresa Bader; Klaus Schröppel; Stefan Bentink; Nina Agabian; Gerwald Köhler; Joachim Morschhäuser
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.

Authors:  Sabrina Schubert; P David Rogers; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

5.  Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate.

Authors:  Davina Hiller; Stephanie Stahl; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

6.  Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans.

Authors:  Davina Hiller; Dominique Sanglard; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  MDR1-mediated drug resistance in Candida dubliniensis.

Authors:  S Wirsching; G P Moran; D J Sullivan; D C Coleman; J Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  A stable hybrid containing haploid genomes of two obligate diploid Candida species.

Authors:  Uttara Chakraborty; Aiyaz Mohamed; Pallavi Kakade; Raja C Mugasimangalam; Parag P Sadhale; Kaustuv Sanyal
Journal:  Eukaryot Cell       Date:  2013-05-24

9.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

10.  The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.

Authors:  Gary Moran; Derek Sullivan; Joachim Morschhäuser; David Coleman
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.